Rescue cat’s legacy expands feline heart research at NC State
Bottom line
A rescue Sphynx cat named Vladimir, described as a shelter “rebel,” is the inspiration behind a growing feline cardiology research legacy at NC State’s College of Veterinary Medicine. In an April 14, 2026 profile, the college said Vladimir’s pet parent, Amos Cader, turned grief into philanthropy after Vladimir died of hypertrophic cardiomyopathy, or HCM. That support has now expanded beyond donations into a named research fellow position, an annual early-career feline research award, and the Vladimir Cader Feline Health Research Distinguished Chair, announced this spring with NC State cardiologist and associate dean Joshua Stern as the inaugural recipient. (cvm.ncsu.edu)
Why it matters: For veterinary professionals, this is more than a donor profile. It shows how client and pet parent experiences can directly shape research infrastructure in areas where unmet need remains high. HCM is the most common form of heart disease in cats and affects up to 15% of the feline population, with Sphynx cats among the breeds considered predisposed. NC State has positioned the Cader-backed effort around long-term feline HCM discovery, trainee support, and translation to practice through Stern’s program, which has already helped advance the first conditionally approved drug for management of ventricular hypertrophy in cats with subclinical HCM. (vet.cornell.edu)
What to watch: Watch how NC State uses this endowed funding to sustain feline HCM trials, recruit talent, and build on the ongoing FDA pathway for HCM therapeutics in cats. (cvm.ncsu.edu)
A rescue cat with a reputation for being unadoptable is now the namesake of a growing feline health research platform at NC State. In “The Rescued ‘Rebel’ that Inspired an Unending Scientific Legacy,” published April 14, 2026, the NC State College of Veterinary Medicine traced how Amos Cader’s bond with his Sphynx cat Vladimir led to a series of philanthropic investments after Vladimir died of hypertrophic cardiomyopathy, or HCM. Those investments now include support for research trainees and a newly created distinguished chair in feline health research. (cvm.ncsu.edu)
The backstory matters. According to NC State, Vladimir was rescued from an Ohio shelter after multiple failed placements, but quickly bonded with Cader and later became a constant companion to Amos and Anna Cader. After Vladimir developed HCM, Cader searched for treatment options and eventually connected with Joshua Stern, NC State’s associate dean of research and graduate studies, whose lab focuses on feline cardiology and HCM. That relationship appears to have evolved from personal outreach into a broader, structured funding strategy. (cvm.ncsu.edu)
NC State’s separate April 14, 2026 announcement fills in the institutional details. The Caders first supported ongoing research, then created the Vladimir Cader Early Innovator in Feline Research Award, which recognizes NC State trainees for feline-focused research, and most recently endowed the Vladimir Cader Feline Health Research Distinguished Chair. NC State said Stern is the first recipient. A later college roundup reiterated that appointment, signaling that the chair is now part of the college’s formal academic structure. (cvm.ncsu.edu)
This story also lands in the middle of a larger shift in feline cardiology. HCM is the most common feline heart disease, affecting up to 15% of cats, according to Cornell’s Feline Health Center, and Sphynx cats are among the breeds with recognized predisposition. Stern has become a prominent figure in that field; NC State News reported in June 2024 that he received the American Veterinary Medical Foundation’s Career Achievement in Feline Research Award, citing his work on a disease-modifying treatment for feline HCM. (vet.cornell.edu)
The most concrete translational milestone is regulatory. FDA records show that on March 14, 2025, the agency granted conditional approval to felycin-CA1, a sirolimus delayed-release tablet from TriviumVet, for management of ventricular hypertrophy in cats with subclinical HCM. The FDA’s FOI summary describes the product as conditionally approved while effectiveness data continue to be developed, and FDA guidance notes that conditional approval is intended to bring certain animal drugs to market sooner for serious conditions or unmet needs. NC State has tied Stern’s research program directly to that development pipeline, and the college says the product is now in its pivotal phase. (fda.gov)
Industry and academic reaction, at least from NC State and affiliated channels, has been strikingly direct. In the distinguished chair announcement, Stern called the Caders’ support “transformational” because the endowment will generate annual funding in perpetuity for feline heart disease research. In the 2024 NC State News piece, AVMA president Rena Carlson said Stern’s work had advanced understanding and treatment of feline HCM and offered hope for affected cats. While those comments come from parties close to the program, they underscore how unusual it is in veterinary medicine for an individual patient story to mature into a durable research endowment with clear translational aims. (cvm.ncsu.edu)
Why it matters: For veterinary professionals, the significance is less about one memorial story and more about what it reveals about the feline research ecosystem. Cat-focused research has historically lagged behind canine funding in many areas, and endowed support tied to a specific disease can create continuity for faculty recruitment, trainee development, biobanking, clinical trials, and eventually practice change. In this case, the Cader gifts are reinforcing a center already active in genetics, pharmacology, and clinical HCM studies, which could accelerate both earlier detection and more disease-specific management options for cats seen in general and specialty practice. (pmc.ncbi.nlm.nih.gov)
What to watch: The next markers will be whether NC State expands enrollment in ongoing HCM studies, whether felycin-CA1 progresses from conditional to full FDA approval during its multiyear pivotal program, and whether the distinguished chair helps attract additional feline-focused philanthropy and faculty capacity. (cvm.ncsu.edu)